Login / Signup

Functional homologous recombination assay on FFPE specimens of advanced high-grade serous ovarian cancer predicts clinical outcomes.

Sanna PikkusaariManuela TumiatiAnni VirtanenJaana OikkonenYilin LiFernando Pérez-VillatoroTaru A MuranenMatilda SalkoKaisa HuhtinenAnna KanervaHeidi KoskelaJohanna TapperRiitta Koivisto-KoranderTitta JoutsiniemiUlla-Maija HaltiaHeini LassusSampsa HautaniemiAnniina FarkkilaJohanna HynninenSakari HietanenOlli CarpenLiisa Kauppi
Published in: Clinical cancer research : an official journal of the American Association for Cancer Research (2023)
We developed a functional HR assay performed on routine FFPE specimens, obtained from either chemo-naïve or NACT-treated HGSC patients, that can significantly predict real-world platinum-based chemotherapy and PARPi response.
Keyphrases